Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is expected to have strong revenue growth, driven by their successful U.S. sales and expanding into international markets. Additionally, their innovative and minimally invasive surgery techniques, along with a strong pipeline of products, are expected to drive future growth. The company's recent beat-and-raise quarter, increased revenue guidance for the full year 2026, and continued momentum in sales support a positive outlook for the stock. While there are risks such as economic downturns and competition, the potential upside drivers include stronger than expected sales and margins. My 12-month price target for this stock is $90 based on an 8.5x multiple applied to the 12-24 month revenue estimate.

Bears say

Establishment Labs Hldgs is facing significant challenges, such as slow sales growth and difficulties in achieving profitability, particularly in the US market. The company's high valuation of 11x EV/sales in 2026 relies heavily on optimistic revenue projections, making it vulnerable to any potential setbacks or delays. With a relatively limited product portfolio and a history of negative earnings, the company's financial health is at risk and may not support long-term sustainable growth.

ESTA has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 7 analysts, ESTA has a Buy consensus rating as of Jun 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.